Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP studyMichael H. Albert, Cristina Díaz de Heredia, Tiarlan Sirait et al.|Blood|2022Cited by 57
Durable Clinical Benefits with Exagamglogene Autotemcel for Transfusion-Dependent β-ThalassemiaFranco Locatelli, Haydar Frangoul, Peter Lang et al.|Blood|2024Cited by 4
Improvements in health-related quality of life in patients with transfusion-dependent β-thalassemia after exagamglogene autotemcelJosu de la Fuente, Franco Locatelli, Haydar Frangoul et al.|Blood Advances|2025Cited by 3
Durable Clinical Benefits in Transfusion-Dependent Β-Thalassemia with Exagamglogene AutotemcelHaydar Frangoul, William Hobbs, Franco Locatelli et al.|Transplantation and Cellular Therapy|2025Cited by 1
S225: ALLOGENEIC STEM CELL TRANSPLANTATION FOR NK/T-CELL LYMPHOMA IN THE ERA OF ASPARAGINASE-BASED CHEMOTHERAPY: A RETROSPECTIVE ANALYSIS OF THE EBMT LYMPHOMA WORKING PARTYPhilipp Berning, Bertram Glaß, Norbert Schmitz et al.|HemaSphere|2023Cited by 0